Back to Search
CHRISTIAN BOGNER, M.D.
M.D.
Integrative Medicine Physician
NPI: 1396956504Individual
Specialties, Licenses & Credentials
Research & Publications (12)
The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells.
PMID 17805332·Leukemia·2008
8-other
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.
PMID 17626842·Blood·2007
8-other
Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
PMID 16856892·Br J Haematol·2006
8-other
Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
PMID 16538501·Ann Hematol·2006
8-other
Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.
PMID 16437144·Leukemia·2006
8-other
Targeting the proteasome in mantle cell lymphoma: a promising therapeutic approach.
PMID 16321849·Leuk Lymphoma·2006
6-review
Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells.
PMID 16219581·Haematologica·2005
4-observational
Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.
PMID 12846895·Br J Haematol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 1524 WASHINGTON BLVD
BIRMINGHAM, MI 48009 - Phone
- (248) 931-8811
Quick Facts
- NPI
- 1396956504
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 4
- Publications
- 12
Are you this provider?
Claim Your Profile